indobufen has been researched along with Bleeding in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bath, PM; Chen, W; Dong, Q; Jiang, Y; Jing, J; Johnston, SC; Li, H; Lin, J; Meng, X; Pan, Y; Wang, Y; Xu, AD | 1 |
| Chen, M; Cheng, K; Ge, J; Huang, J; Lan, J; Li, G; Qian, J; Wang, X; Wang, Y; Wei, G; Wu, H; Xu, L; Zhang, C; Zhang, H; Zhao, X | 1 |
| Chen, HY; Gao, XY; He, Q; Jin, J; Li, H; Li, YW; Lin, B; Liu, YM; Qu, K; Wang, H; Xiong, XL; Yu, XY; Zheng, DN | 1 |
| Bochicchio, O; Gargiulo, M; Palombi, M; Sammarco, M | 1 |
| Bassi, A; Borghi, B; Feoli, MA; Grazia, M; Pignotti, E | 1 |
| Cohen, H; Ebrahim, S; Taylor, FC | 1 |
| Prisco, D | 1 |
| Pengo, V | 1 |
2 review(s) available for indobufen and Bleeding
| Article | Year |
|---|---|
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Hemorrhage; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Warfarin | 2001 |
[Thromboembolism in non-rheumatic atrial fibrillation].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Consensus Development Conferences as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electric Countershock; Female; Hemorrhage; Humans; Incidence; International Normalized Ratio; Isoenzymes; Isoindoles; Male; Membrane Proteins; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2001 |
4 trial(s) available for indobufen and Bleeding
| Article | Year |
|---|---|
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial.
Topics: Aspirin; Brain Ischemia; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome | 2022 |
Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point-Blinded, Noninferiority Trial.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Ischemic Stroke; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombosis; Treatment Outcome; Troponin | 2023 |
Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Fibrinolytic Agents; Hemorrhage; Humans; Nephrotic Syndrome; Thromboembolism; Treatment Outcome; Warfarin | 2023 |
[Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Isoindoles; Male; Middle Aged; Orthopedics; Phenylbutyrates; Platelet Aggregation Inhibitors; Postoperative Complications; Thromboembolism | 1996 |
2 other study(ies) available for indobufen and Bleeding
| Article | Year |
|---|---|
[Alternative therapy of deep venous thrombosis in patients at hemorrhagic risk].
Topics: Aged; Bandages; Fibrinolytic Agents; Hemorrhage; Humans; Isoindoles; Male; Phenylbutyrates; Polydeoxyribonucleotides; Risk Factors; Thrombophlebitis; Ultrasonography | 1994 |
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Diabetes Complications; Double-Blind Method; Fibrinolytic Agents; Heart Valve Diseases; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Warfarin | 2001 |